Vir Bio CFO Jason O'Byrne to step down; Brent Sabatini named interim principal financial officer

Vir Biotechnology, Inc.

CFO Jason O'Byrne resigns effective August 3, 2026, to pursue another opportunity; no disagreement with company.
Board appoints Brent Sabatini, SVP and CAO, as interim principal financial officer effective same date.
Sabatini has been CAO since Oct 2024, previously at Capsida and Amgen; no additional compensation for interim role.
Search for permanent CFO initiated.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.